Human ICAM-1/CD54 Allele-specific Quantikine ELISA Kit
| Name | Human ICAM-1/CD54 Allele-specific Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DCD540 |
| Category | ELISA Kit |
| Prices | $509.00, $2,440.00, $16,540.00 |
| Sizes | 1 kit, 1 pack (6 Plates), 1 pack (50 Plates) |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (100 uL), Serum (10 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL) |
| Sensitivity | 0.254 ng/mL |
| Range | 1.6 - 50 ng/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human sICAM-1 immunoassay is a 2.0 hour solid phase ELISA designed to measure sICAM-1 in cell culture supernates, serum, and plasma |
| Gene | ICAM1 |
| Supplier Page | Shop |
Product images
Product References
Altered Monocyte and Endothelial Cell Adhesion Molecule Expression Is Linked to - Altered Monocyte and Endothelial Cell Adhesion Molecule Expression Is Linked to
Kulkarni M, Bowman E, Gabriel J, Amburgy T, Mayne E, Zidar DA, Maierhofer C, Turner AN, Bazan JA, Koletar SL, Lederman MM, Sieg SF, Funderburg NT. Open Forum Infect Dis. 2016 Oct 15;3(4):ofw224.
Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and - Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and
Przepiera-Bedzak H, Fischer K, Brzosko M. Int J Mol Sci. 2016 Aug 3;17(8). pii: E1255.
Immune-inflammatory markers and arterial stiffness indexes in subjects with acute - Immune-inflammatory markers and arterial stiffness indexes in subjects with acute
Tuttolomondo A, Pecoraro R, Di Raimondo D, Di Sciacca R, Canino B, Arnao V, Butta C, Della Corte V, Maida C, Licata G, Pinto A. Diabetol Metab Syndr. 2014 Feb 27;6(1):28.
Association between traffic-related air pollution, subclinical inflammation and - Association between traffic-related air pollution, subclinical inflammation and
Teichert T, Vossoughi M, Vierkotter A, Sugiri D, Schikowski T, Schulte T, Roden M, Luckhaus C, Herder C, Kramer U. PLoS One. 2013 Dec 10;8(12):e83042.
The type and quantity of dietary fat and carbohydrate alter faecal microbiome and - The type and quantity of dietary fat and carbohydrate alter faecal microbiome and
Fava F, Gitau R, Griffin BA, Gibson GR, Tuohy KM, Lovegrove JA. Int J Obes (Lond). 2013 Feb;37(2):216-23.
Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus - Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus
Miles DW, de Haas SL, Dirix LY, Romieu G, Chan A, Pivot X, Tomczak P, Provencher L, Cortes J, Delmar PR, Scherer SJ. Br J Cancer. 2013 Mar 19;108(5):1052-60.
Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary - Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary
Braicu EI, Fotopoulou C, Chekerov R, Richter R, Blohmer J, Kummel S, Stamatian F, Yalcinkaya I, Mentze M, Lichtenegger W, Sehouli J. Cytokine. 2013 Mar;61(3):755-8.
Plasma concentrations predict aortic expression of growth-arrest-specific protein - Plasma concentrations predict aortic expression of growth-arrest-specific protein
Lee CH, Shieh YS, Tsai CS, Hung YJ, Tsai YT, Lin CY. PLoS One. 2013 Nov 13;8(11):e79452.
Systemic biomarkers of inflammation and haemostasis in patients with chronic - Systemic biomarkers of inflammation and haemostasis in patients with chronic
Rodland EK, Ueland T, Bjornsen S, Sagen EL, Dahl CP, Naalsund A, Mollnes TE, Brosstad FR, Muller F, Aukrust P, Froland SS. BMC Infect Dis. 2012 Jun 25;12:144.
Mechanisms of endothelial dysfunction in resistance arteries from patients with - Mechanisms of endothelial dysfunction in resistance arteries from patients with
Luksha L, Stenvinkel P, Hammarqvist F, Carrero JJ, Davidge ST, Kublickiene K. PLoS One. 2012;7(4):e36056.